The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from in the DAA era: A population-based study.

Sofia R BartlettStanley WongAmanda YuMargo PearceJulia MacIsaacSusan NouchPrince AduJames WiltonHasina SamjiEmilia ClementiHector VelasquezDahn JeongMawuena BinkaMaria AlvarezJason WongJane BuxtonMel KrajdenNaveed Z Janjua

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Current OAT was associated with a higher likelihood of HCV treatment initiation. However, many PWUD with HCV currently receiving OAT have yet to receive HCV treatment. Enhanced integration between substance use care and HCV treatment is needed to improve the overall health of PWUD.

Keyphrases

hepatitis c virus
healthcare
human immunodeficiency virus
public health
palliative care
chronic pain
combination therapy
replacement therapy